Your session is about to expire
← Back to Search
Sleep Programs for Discontinuing Sleeping Medications (SWITCH Trial)
N/A
Waitlist Available
Led By Constance Fung, MD, MSHS
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months after treatment ends
Awards & highlights
SWITCH Trial Summary
This trial is testing whether a program to address placebo effects associated with taking sleeping medications can help people discontinue use of the medications better than a standard program.
SWITCH Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ an average of 9 weeks from randomization and 6 months after treatment ends
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~an average of 9 weeks from randomization and 6 months after treatment ends
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Dysfunctional Beliefs and Attitudes About Sleep - Medication Scale ratings
Hypnotic dose
Insomnia Severity Index
+1 moreOther outcome measures
Digit Symbol Substitution
Mini-Mental State Examination
One-leg Balance test
+1 moreSWITCH Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Program AExperimental Treatment1 Intervention
cognitive behavioral therapy type A plus medications in packaging type A
Group II: Program BActive Control1 Intervention
cognitive behavioral therapy type B plus medications in packaging type B
Find a Location
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,530 Previous Clinical Trials
10,278,014 Total Patients Enrolled
US Department of Veterans AffairsFED
868 Previous Clinical Trials
487,702 Total Patients Enrolled
Virginia Commonwealth UniversityOTHER
698 Previous Clinical Trials
22,884,807 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are not a good fit for therapy to help with sleeping problems if you do not have a stable place to live.You have a high risk of having complications if you stop taking the sleep medication while not in the hospital. For example, if you have a seizure disorder.You are at high risk for problems if you stop taking your sleep medication while not in the hospital. This includes taking a high dose of the medication.You are at high risk for problems if you stop taking sleep medication at home, especially if you use multiple drugs like strong painkillers.You currently have trouble sleeping or have had trouble sleeping in the past.You are 55 years old or older.You have used certain medications for insomnia at least 2 nights a week for 3 months or more.You have a high risk of having severe withdrawal symptoms or complications if you stop taking sleeping pills or anxiety medication outside of the hospital.You have a high risk of complications during a program to stop taking sleeping pills outside of a hospital. This could include signs that you're getting the medication in a dishonest way, like getting multiple prescriptions for the same drug from different pharmacies at the same time.You are using the study-targeted hypnotic to treat another health condition, such as panic disorder, and it's not suitable for you to stop using it.You have bipolar disorder and may not benefit from cognitive behavioral therapy for insomnia.You have trouble with your memory or thinking.Your sleep problems are caused by a different sleep disorder, like restless legs syndrome or narcolepsy, rather than just difficulty falling or staying asleep.You have untreated breathing problems during sleep and excessive daytime sleepiness.You are not a good fit for therapy to help with sleep problems if you have ongoing serious medical or mental health issues like planned major surgery, psychosis, or active alcohol/substance abuse.
Research Study Groups:
This trial has the following groups:- Group 1: Program A
- Group 2: Program B
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the research still open for participants?
"As per the clinicaltrials.gov website, this particular research trial is not currently enrolling new participants. Originally posted on December 11th 2018 and last updated May 16th 2022, no further recruitment efforts are being made at present; however, there are 207 other study sites actively looking for patients to join their trials."
Answered by AI
Who else is applying?
What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
University of California, Los Angeles
What portion of applicants met pre-screening criteria?
Met criteria
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger